Sign in

CIK 0001727196

  • Non-accelerated filer

Scholar Rock Holding Corp

Sign in to watch
Ticker
SRRK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
823750435
Phone
+1 857-259-3860
Business address
301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
  1. 4 Grant or award CEO acquired 1,500,000 shares (grant or award)
  2. 4 Grant or award Chief Financial Officer acquired 600,000 shares (grant or award)
  3. 4 Planned sale Chief Commercial Officer sold 5,000 shares at an average $32.83 ($164,131)
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 4 Planned sale Chief Commercial Officer sold 6,500 shares at an average $33.08 ($215,014)
  7. 4 Planned sale Interim PFO and PAO sold 13,564 shares at $33.12 ($449,237)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Planned sale Director sold 1,006 shares at $34.42 ($34,627)
  10. 4 Planned sale COO & CFO sold 142,292 shares at an average $35.62 ($5,068,974)
  11. 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 32,145 shares (grant or award)
  12. 4 Grant or award CHRO acquired 23,570 shares (grant or award)
  13. 4 Grant or award CHIEF MEDICAL OFFICER acquired 34,285 shares (grant or award)
  14. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 113,570 shares (grant or award)
  15. 4 Grant or award GENERAL COUNSEL acquired 32,145 shares (grant or award)
  16. 4 Grant or award Chief Commercial Officer acquired 27,855 shares (grant or award)
  17. 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 72,645 shares at an average $37.37 ($2,714,767)
  18. 4 Open-market sale CHRO sold 5,296 shares at $36.83 ($195,046)
  19. 4 Open-market sale COO & CFO sold 7,809 shares at $36.83 ($287,598)
  20. 4 Open-market sale GENERAL COUNSEL sold 5,742 shares at $36.83 ($211,472)

Page 5 of 17 · 321 filings